1. Home
  2. PDFS vs COLL Comparison

PDFS vs COLL Comparison

Compare PDFS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDFS
  • COLL
  • Stock Information
  • Founded
  • PDFS 1992
  • COLL 2002
  • Country
  • PDFS United States
  • COLL United States
  • Employees
  • PDFS N/A
  • COLL N/A
  • Industry
  • PDFS EDP Services
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDFS Technology
  • COLL Health Care
  • Exchange
  • PDFS Nasdaq
  • COLL Nasdaq
  • Market Cap
  • PDFS 1.1B
  • COLL 1.0B
  • IPO Year
  • PDFS N/A
  • COLL 2015
  • Fundamental
  • Price
  • PDFS $27.55
  • COLL $32.59
  • Analyst Decision
  • PDFS Strong Buy
  • COLL Strong Buy
  • Analyst Count
  • PDFS 3
  • COLL 5
  • Target Price
  • PDFS $42.33
  • COLL $43.80
  • AVG Volume (30 Days)
  • PDFS 168.3K
  • COLL 426.9K
  • Earning Date
  • PDFS 02-13-2025
  • COLL 02-20-2025
  • Dividend Yield
  • PDFS N/A
  • COLL N/A
  • EPS Growth
  • PDFS 56.69
  • COLL 757.11
  • EPS
  • PDFS 0.11
  • COLL 2.16
  • Revenue
  • PDFS $170,505,000.00
  • COLL $599,245,000.00
  • Revenue This Year
  • PDFS $9.87
  • COLL $13.25
  • Revenue Next Year
  • PDFS $19.37
  • COLL $18.14
  • P/E Ratio
  • PDFS $251.18
  • COLL $15.07
  • Revenue Growth
  • PDFS 3.19
  • COLL 9.62
  • 52 Week Low
  • PDFS $26.60
  • COLL $28.39
  • 52 Week High
  • PDFS $39.70
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • PDFS 43.15
  • COLL 56.03
  • Support Level
  • PDFS $26.60
  • COLL $31.19
  • Resistance Level
  • PDFS $29.12
  • COLL $33.99
  • Average True Range (ATR)
  • PDFS 0.88
  • COLL 1.42
  • MACD
  • PDFS 0.13
  • COLL 0.14
  • Stochastic Oscillator
  • PDFS 32.76
  • COLL 74.01

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: